 |
 |
http://biz.yahoo.com/bw/980709/novatellig_1.html Thursday July 9, 4:42 pm Eastern Time Company Press Release ISAMED Enters Clinical Evaluation for Use with Parkinson's Patients SAN DIEGO--(BW HealthWire)--July 9, 1998--NovaTelligence has just announced the commencement of a two-month clinical evaluation process to precede the release of their newest product. Under development for over 11 years, ISAMED \226 a computerized assessment and reminder system \226 is currently undergoing a preliminary evaluation in the Department of Neurology, University of Southern California School of Medicine. The evaluation, under the direction of Cheryl Waters, M.D., Chief of the USC Division of Movement disorders, will determine what improvements, if any, should be made to the product to increase its ease of use. The ISAMED system consists of two computerized components \226 one for the physician and one for the patient - which work together to monitor and manage the ongoing condition of Parkinson's patients and their response to medications related to the treatment of Parkinson's disease. ISAMED Pocket - the patient component \226 assists patients with their often complex medication schedules and records information about their symptoms, side effects, diets and activity levels. The recorded information is then transferred to ISAMED Clinic \226 the neurologist component \226 where it can be analyzed in graphical or tabular format, allowing the neurologist to fine-tune the patient's medication schedule and recommend lifestyle changes as needed. ``I think that the development of the handheld computer will take our capacity for patient care to a higher level,'' said Mark Lew, M.D., USC Associate Professor of Neurology, Division of Movement Disorders. ``We will be able to better understand and monitor a patient's response to treatment and subsequently offer them improved pharmacological management.'' -- Judith Richards, London, Ontario, Canada [log in to unmask]